Mesoblast Still Hopes To Show Utility Of Allogeneic Stem Cell Therapy In COVID-19

 
• By Joseph Haas
Coronavirus map
Mesoblast was unable to replicate earlier data in treating COVID-19 infections

More from Clinical Trials

More from R&D